0.8895
price down icon1.67%   -0.0103
 
loading

Clearside Biomedical Inc Azioni (CLSD) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
96.38%
0.23
6.345 0.859 1.018 0.004
Operating Expenses
8.87%
8.439
9.26 7.913 8.288 7.609
Benefits Costs and Expenses
7.30%
11.99
11.18 - - 9.284
Costs And Expenses
7.30%
11.99
11.18 7.913 8.288 9.284
Operating Income/Loss
181.61%
-8.209
-2.915 -7.054 -7.27 -7.605
Income/Loss From Continuing Operations Before Tax
143.44%
-11.76
-4.832 0.859 -9.106 -9.28
Income/Loss From Continuing Operations After Tax
143.44%
-11.76
-4.832 -9.267 -9.106 -9.28
Net Income/Loss
143.44%
-11.76
-4.832 -9.267 -9.106 -9.28
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
34,599%
69.85
0.2013 61.98 61.65 61.17
Diluted Average Shares
34,599%
69.85
0.2013 61.98 61.65 61.17
Basic Earnings Per Share
112.50%
-0.17
-0.08 -0.15 -0.15 -0.15
Diluted Earnings Per Share
112.50%
-0.17
-0.08 -0.15 -0.15 -0.15
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$66.10
price down icon 2.65%
$73.33
price down icon 0.15%
$31.60
price up icon 0.06%
$18.91
price down icon 11.53%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 7.93%
Capitalizzazione:     |  Volume (24 ore):